Thursday, December 6, 2018 - Investor Ideas Potcasts #Cannabis News and Stocks on the Move: (CSE: $TGIF.C) (TSX: $WEED.TO) (NYSE: $CGC) (CSE: $HUGE.C) (CSE: $OVAT.C) - Investor Ideas Potcasts #Cannabis News and Stocks on the Move: (CSE: $TGIF.C) (TSX: $WEED.TO) (NYSE: $CGC) (CSE: $HUGE.C) (CSE: $OVAT.C)

Investor Ideas Potcasts #Cannabis News and Stocks on the Move: (CSE: $TGIF.C) (TSX: $WEED.TO) (NYSE: $CGC) (CSE: $HUGE.C) (CSE: $OVAT.C)

This month’s cannabis podcasts brought to you by CLS Holdings USA, Inc. (OTCQB: $CLSH) @CLSHusa

Delta, Kelowna, BC - December 6, 2018 ( Newswire), a global news source covering leading sectors including marijuana and hemp stocks and its potcast site, and its exclusive content partner, CLS Holdings USA, Inc. (OTCQB: CLSH), release today's edition of potcastsCM - cannabis news and stocks to watch plus insight from thought leaders and experts.
CLS Holdings USA, Inc. (OTCQB: CLSH) is a diversified cannabis company operating as Cannabis Life Sciences an integrated cannabis producer and retailer in Nevada through its Oasis Cannabis subsidiaries with plans to expand into other States.

Investor Ideas Potcasts #Cannabis News and Stocks on the Move: (CSE: $TGIF.C) (TSX: $WEED.TO) (NYSE: $CGC) (CSE: $HUGE.C) (CSE: $OVAT.C)

Hear Investor ideas cannabis potcast on iTunes

Today's podcast overview/transcript:
Good afternoon, welcome to another "potcast", featuring stocks to watch, cannabis news as well as insights from thought leaders and experts.
Today we will be looking at announcements from 1933 Industries Inc. (CSE: TGIF) (OTCQX: TGIFF), Canopy Growth Corporation (TSX: WEED) (NYSE: CGC), FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) and Ovation Science Inc. (CSE: OVAT).
1933 Industries Inc. a licensed cultivator and producer of cannabis flower and concentrates and manufacturer of hemp/CBD products in Nevada, Colorado and California, announced that it has met the eligibility requirements and has been accepted for trading on the OTCQX®, the OTC Markets' premier tier. The Company's common shares will continue to trade under the symbol TGIFF. The OTCQX® Best Market top tier is for established, high-growth and investor-focused companies wishing to gain added exposure in the United States.
Companies trading on the OTCQX® Best Market are distinguished by the integrity of their operations, have met certain financial asset tests and have demonstrated compliance with US securities laws and with disclosure requirements. OTCQX companies gain added exposure to US retail and institutional investors.
"Meeting the OTCQX® Best Market high financial and corporate governance standards was a significant milestone for the Company during our first year of trading", commented Mr. Brayden Sutton, President and CEO of 1933 Industries. He added, "As a US-focused issuer, we view graduating to the OTCQX® Best Market as an important step in our Company's growth. Not only does it provide greater visibility and profile for our Company as we continue to penetrate legal markets in the US, but it allows us to connect with an expanded and diverse network of potential investors".
Canopy Growth Corporation has finalized an all-cash transaction to acquire Storz & Bickel GmbH & Co. KG, related entities, and IP for a purchase price of up to approximately €145 million. With a 22-year track record of breakthrough innovations, Storz & Bickel is widely recognized as the global leader in vaporizer design and manufacturing.
Based in Tuttlingen, Germany, Storz & Bickel are designers and manufacturers of medically approved vaporizers, most notably the Volcano® Medic and the Mighty® Medic. Storz & Bickel has spent the last two decades developing an automated and internationally certified factory, achieving ISO 13485 certification in 2009. The company has exported devices to 50 markets around the world.
The acquisition will see Storz & Bickel's eponymous founders Markus Storz and J├╝rgen Bickel remaining as a part of the organization to continue driving the business forward alongside Canopy Growth's management.
"We view this as a marquee acquisition of the most recognized technology company in the industry," said Bruce Linton, Chairman & Co-CEO, Canopy Growth. "This Company is well positioned for the next wave of federally-regulated products in Canada beyond dried flower and edible oils. By combining Canopy's existing designs and Canada's open environment for federally permissible R&D with Storz & Bickel's deep IP portfolio and management team, Canopy Growth is poised to lead the high-margin vaporizing category around the world."
FSD Pharma Inc., which, through its wholly-owned subsidiary, FV Pharma Inc., is a licensed producer pursuant to the Cannabis Act, announced today that it has entered into a definitive Collaboration and License Agreement (the "Agreement") with World Class Extractions Inc., a company that has developed a unique extraction process designed to produce quality, potent cannabis extracts. World Class is also in the process of completing its own previously announced reverse takeover of CBD Med Research Corp., and submitted its initial listing application to the Canadian Securities Exchange late last week.
Under the terms of the agreement and a related lease, FSD Pharma will provide World Class with space at its 620,000 square foot facility in Cobourg, Ontario, assist it in obtaining an extraction license from Health Canada, and provide World Class with the raw cannabis needed to produce cannabis extracts. In return, World Class will provide FSD Pharma with certain royalty rights over the profits derived from the sale of those cannabis extracts.
FSD Pharma will provide World Class with up to 5,000 square feet of space at the FSD Facility. World Class will build and install, at its expense, its own manufacturing facility within the larger FSD Facility, at which it intends to extract and process CBD enriched oil and other extracts. In addition, FSD Pharma will assist World Class in preparing an application to Health Canada under the Cannabis Act to obtain the necessary license to carry out its cannabis extraction activities.
Ovation Science Inc., a skincare research and development company with the objective to be the leader in the topical and transdermal cannabis market by leveraging its patented skin delivery technology, announced the launch of a third product in the USA by its licensee.
Ovation management has over twenty years of topical drug delivery experience and has leveraged this experience and technology to develop a series of topical and transdermal cannabis products. Ovation's products have many advantages over cannabis products that are smoked or ingested including avoiding the side-effects from smoking and eliminating the first pass effect through the liver (which reduces the amount of CBD / THC available and increasing the onset time). Today, Ovation is announcing the launch of a third product into the US market.
"Lighthouse, our US licensee and Cannabiniers our cannabis branding experts, have already successfully launched two products under the brand "BASKiN" with excellent consumer feedback. We are excited that they have now launched BASKiN Sport, the first CBD product line extension that targets the health and fitness industry as a pre and post work-out enhancer," said Terry Howlett, President of Ovation. "Our goal is for our products to become the gold-standard in the topical cannabis market, adding both revenue and creating shareholder value as we expand our distribution through our licensees globally. He added, "This product launch coincides with our new listing on the CSE under the ticker symbol OVAT; so it's been an exciting couple of weeks."
Ovation's business model is to develop and license-out its topical and transdermal formulations to cannabis companies globally. Ovation products are unique from other infused product companies as it leverages its expertise in the pharmaceutical industry to develop highly effective, patent-protected products and has the results to prove it. Ovation products are used for improved wellness, pain management and even anti-aging, to name a few. Ovation earns revenues from licensing and development fees, royalties and the sale of Invisicare to its licensees. Ovation's licensees currently include Canopy Growth Corporation in Canada and Lighthouse Strategies, LLC in the USA.
Investor ideas reminds all listeners to read our disclaimers and disclosures on the website and this podcast is not an endorsement to buy products or services or securities. Investors are reminded all investment involves risk and possible loss of investment

This podcast is sponsored by

CLS Holdings USA, Inc. (OTCQB: CLSH)
CLS Holdings USA, Inc. (CLSH) is a diversified cannabis company that, subject to receipt of certain anticipated regulatory approvals, acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada, and plans to expand to other states.
CLS stands for "Cannabis Life Sciences," in recognition of the Company's patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The Company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services.
For additional information, please visit:
Twitter: @CLSHusa

Subscribe to the new cannabis podcast series:
To hear more podcasts visit:
Potcasts is now a certified word mark Trademark on the blockchain through Cognate, Inc. CM Certification-Registration Number: 10468217708

Get the cannabis/hemp stock directory as an Investor ideas member, plus get weekly updates with new pot stocks added and get the daily potcast for Investor Ideas #Potcasts #Cannabis News and Stocks on the Move. Learn more

About - News that Inspires Big Investing Ideas is a recognized news source publishing third party news and press releases plus we create original financial content. Learn about investing in stocks and sector trends from with our news alerts , articles , podcasts and videos talking about cannabis, crypto, technology including AI and IoT , mining ,sports biotech, water, renewable energy and more . original branded content includes the daily Crypto Corner and Podcast, Play by Play sports and stock news column, Investor Ideas #Potcasts#Cannabis News and Stocks on the Move podcast and column, Cleantech and Climate Change Podcast and the AI Eye Podcast and column covering developments in AI.
Disclaimer/Disclosure: is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers.
Disclosure this podcast is in partnership with featured sponsor CLS Holdings USA, Inc. (OTCQB: CLSH) details :
More disclaimer info: Learn more about Investor ideas podcast and news publication services and costs
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: Global investors must adhere to regulations of each country.
Please read privacy policy:
Investor Ideas does not condone the use of cannabis except where permissible by law. Our site does not possess, distribute, or sell cannabis products.
Follow us on Social Media

No comments:

Post a Comment